Review in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Biology · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Alfredo Valdez-MartinezSección de Micología, Hospital General "Dr. Manuel Gea González", Mexico City 14080, Mexico.
Mónica Ingrid Santoyo-AlejandreFacultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Mexico City 04510, Mexico.
Roberto ArenasSección de Micología, Hospital General "Dr. Manuel Gea González", Mexico City 14080, Mexico.ORCID 0000-0002-2992-9564
Mariel A Isa-PimentelCo Coordinación de Residencia, Instituto Dermatológico Dominicano y Cirugía de Piel "Dr. Huberto Bogaert Díaz", Santo Domingo 10306, Dominican Republic.ORCID 0009-0008-4607-5979
Juan Castillo-CruzSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Mexico City 11340, Mexico.ORCID 0000-0002-4943-4374
Karla Daniela Huerta-DomínguezHospital General del Zona 33, Instituto Mexicano del Seguro Social, Nayarit 63735, Mexico.
Erika Fernanda Soto-TorresFacultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Mexico City 04510, Mexico.
Erick Martínez-HerreraSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Mexico City 11340, Mexico.ORCID 0000-0001-7298-158X
Rodolfo Pinto-AlmazánSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Mexico City 11340, Mexico.ORCID 0000-0002-5210-5395
Funding
Instituto Politécnico Nacional 20240377 and 20250764
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.